1. Home
  2. NAGE
  3. NAGE News

Latest Niagen Bioscience Inc. Common Stock (NAGE) News on June 1, 2025

3 Stocks That May Be Trading Below Their Estimated Value
NAGE

Simply Wall St.

12 days ago

3 Stocks That May Be Trading Below Their Estimated Value

Exploring May 2025's Undervalued Small Caps With Insider Action
NAGE

Simply Wall St.

17 days ago

Exploring May 2025's Undervalued Small Caps With Insider Action

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations
NAGE

Simply Wall St.

22 days ago

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
NAGE

GuruFocus.com

24 days ago

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook
NAGE

Business Wire

25 days ago

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide
NAGE

Business Wire

a month ago

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Three High Growth Companies Insiders Are Eager To Hold
NAGE

Simply Wall St.

a month ago

Three High Growth Companies Insiders Are Eager To Hold

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board
NAGE

Business Wire

a month ago

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
NAGE

Business Wire

a month ago

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders
NAGE

Simply Wall St.

a month ago

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs
NAGE

Business Wire

2 months ago

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Growth Companies With High Insider Ownership For April 2025
NAGE

Simply Wall St.

2 months ago

Growth Companies With High Insider Ownership For April 2025

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)
NAGE

Simply Wall St.

2 months ago

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Why ChromaDex Corp (CDXC) Is Surging In 2025?
NAGE

Insider Monkey

2 months ago

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Share on Social Networks: